These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36064725)

  • 21. Patient-Specific iPSC-Derived Neural Differentiated and Hepatocyte-like Cells, Carrying the Compound Heterozygous Mutation p.V1023Sfs*15/p.G992R, Present the "Variant" Biochemical Phenotype of Niemann-Pick Type C1 Disease.
    Völkner C; Liedtke M; Untucht R; Hermann A; Frech MJ
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of miglustat on evolution of atypical presentation of late-infantile-onset Niemann-Pick disease type C with early cognitive impairment, behavioral dysfunction, epilepsy, ophthalmoplegia, and cerebellar involvement: a case report.
    Cuisset JM; Sukno S; Trauffler A; Latour P; Dobbelaere D; Michaud L; Vallée L
    J Med Case Rep; 2016 Sep; 10(1):241. PubMed ID: 27599728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous 2-hydroxypropyl-β-cyclodextrin (Trappsol® Cyclo™) demonstrates biological activity and impacts cholesterol metabolism in the central nervous system and peripheral tissues in adult subjects with Niemann-Pick Disease Type C1: Results of a phase 1 trial.
    Hastings C; Liu B; Hurst B; Cox GF; Hrynkow S
    Mol Genet Metab; 2022 Dec; 137(4):309-319. PubMed ID: 36279795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NPC1 plays a role in the trafficking of specific cargo to melanosomes.
    Rus AA; Militaru IV; Popa I; Munteanu CVA; Sima LE; Platt N; Platt FM; Petrescu ȘM
    J Biol Chem; 2023 Aug; 299(8):105024. PubMed ID: 37423302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial effects of primidone in Niemann-Pick disease type C (NPC)-model cells and mice: Reduction of unesterified cholesterol levels in cells and extension of lifespan in mice.
    Ashikawa H; Mogi H; Honda T; Nakamura H; Murayama T
    Eur J Pharmacol; 2021 Apr; 896():173907. PubMed ID: 33503462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurological Dysfunction in Early Maturity of a Model for Niemann-Pick C1 Carrier Status.
    Hung YH; Walterfang M; Churilov L; Bray L; Jacobson LH; Barnham KJ; Jones NC; O'Brien TJ; Velakoulis D; Bush AI
    Neurotherapeutics; 2016 Jul; 13(3):614-22. PubMed ID: 26942423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C.
    Héron B; Valayannopoulos V; Baruteau J; Chabrol B; Ogier H; Latour P; Dobbelaere D; Eyer D; Labarthe F; Maurey H; Cuisset JM; de Villemeur TB; Sedel F; Vanier MT
    Orphanet J Rare Dis; 2012 Jun; 7():36. PubMed ID: 22676771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Miglustat in Niemann-Pick disease type C patients: a review.
    Pineda M; Walterfang M; Patterson MC
    Orphanet J Rare Dis; 2018 Aug; 13(1):140. PubMed ID: 30111334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular dynamics study with mutation shows that N-terminal domain structural re-orientation in Niemann-Pick type C1 is required for proper alignment of cholesterol transport.
    Yoon HJ; Jeong H; Lee HH; Jang S
    J Neurochem; 2021 Mar; 156(6):967-978. PubMed ID: 32880929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and Molecular Features of Early Infantile Niemann Pick Type C Disease.
    Seker Yilmaz B; Baruteau J; Rahim AA; Gissen P
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated granulocyte-colony stimulating factor and hematopoietic stem cell mobilization in Niemann-Pick type C1 disease.
    Groenen AG; La Rose AM; Li M; Bazioti V; Svendsen AF; Kloosterhuis NJ; Ausema A; Pranger A; Heiner-Fokkema MR; Niezen-Koning KE; Houben T; Shiri-Sverdlov R; Westerterp M
    J Lipid Res; 2022 Feb; 63(2):100167. PubMed ID: 35007562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease.
    Porter FD; Scherrer DE; Lanier MH; Langmade SJ; Molugu V; Gale SE; Olzeski D; Sidhu R; Dietzen DJ; Fu R; Wassif CA; Yanjanin NM; Marso SP; House J; Vite C; Schaffer JE; Ory DS
    Sci Transl Med; 2010 Nov; 2(56):56ra81. PubMed ID: 21048217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired Retromer Function in Niemann-Pick Type C Disease Is Dependent on Intracellular Cholesterol Accumulation.
    Dominko K; Rastija A; Sobocanec S; Vidatic L; Meglaj S; Lovincic Babic A; Hutter-Paier B; Colombo AV; Lichtenthaler SF; Tahirovic S; Hecimovic S
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotype/phenotype of 6 Chinese cases with Niemann-Pick disease type C.
    Xiong H; Higaki K; Wei CJ; Bao XH; Zhang YH; Fu N; Qin J; Adachi K; Kumura Y; Ninomiya H; Nanba E; Wu XR
    Gene; 2012 May; 498(2):332-5. PubMed ID: 22326530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The videofluoroscopic swallowing study shows a sustained improvement of dysphagia in children with Niemann-Pick disease type C after therapy with miglustat.
    Fecarotta S; Amitrano M; Romano A; Della Casa R; Bruschini D; Astarita L; Parenti G; Andria G
    Am J Med Genet A; 2011 Mar; 155A(3):540-7. PubMed ID: 21344635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E genotype and neurological disease onset in Niemann-Pick disease, type C1.
    Fu R; Yanjanin NM; Elrick MJ; Ware C; Lieberman AP; Porter FD
    Am J Med Genet A; 2012 Nov; 158A(11):2775-80. PubMed ID: 23023945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Necroptosis inhibition as a therapy for Niemann-Pick disease, type C1: Inhibition of RIP kinases and combination therapy with 2-hydroxypropyl-β-cyclodextrin.
    Cougnoux A; Clifford S; Salman A; Ng SL; Bertin J; Porter FD
    Mol Genet Metab; 2018 Dec; 125(4):345-350. PubMed ID: 30392741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adult onset Niemann-Pick type C disease and psychosis: literature review].
    Maubert A; Hanon C; Metton JP
    Encephale; 2013 Oct; 39(5):315-9. PubMed ID: 23928063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel compound heterozygous mutations of the NPC1 gene associated with Niemann-pick disease type C: a case report and review of the literature.
    Tao C; Zhao M; Zhang X; Hao J; Huo Q; Sun J; Xing J; Zhang Y; Zhao J; Huang H
    BMC Infect Dis; 2024 Jan; 24(1):145. PubMed ID: 38291356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting defective sphingosine kinase 1 in Niemann-Pick type C disease with an activator mitigates cholesterol accumulation.
    Newton J; Palladino END; Weigel C; Maceyka M; Gräler MH; Senkal CE; Enriz RD; Marvanova P; Jampilek J; Lima S; Milstien S; Spiegel S
    J Biol Chem; 2020 Jul; 295(27):9121-9133. PubMed ID: 32385114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.